VEGFD
Summary: The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family and is active in angiogenesis, lymphangiogenesis, and endothelial cell growth. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms which bind and activate VEGFR-2 and VEGFR-3 receptors. This protein is structurally and functionally similar to vascular endothelial growth factor C. Read-through transcription has been observed between this locus and the upstream PIR (GeneID 8544) locus. [provided by RefSeq, Feb 2011].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| vascular endothelial growth factor D | MIM:300091 | Ensembl:ENSG00000165197 | HGNC:HGNC:3708 | PA28146 | Xp22.2 |
GO terms in VEGFD
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| CC | TAS | GO:0005576 | extracellular region |
| CC | IBA | GO:0005615 | extracellular space |
| CC | IEA | GO:0016020 | membrane |
| CC | TAS | GO:0031093 | platelet alpha granule lumen |
| BP | IBA | GO:0001525 | angiogenesis |
| BP | IBA | GO:0001666 | response to hypoxia |
| BP | IBA | GO:0001934 | positive regulation of protein phosphorylation |
| BP | IBA | GO:0001938 | positive regulation of endothelial cell proliferation |
| BP | IBA | GO:0002040 | sprouting angiogenesis |
| BP | TAS | GO:0002576 | platelet degranulation |
| BP | IEA | GO:0008283 | cell proliferation |
| BP | TAS | GO:0008284 | positive regulation of cell proliferation |
| BP | IEA | GO:0010469 | regulation of signaling receptor activity |
| BP | IBA | GO:0038084 | vascular endothelial growth factor signaling pathway |
| BP | IBA | GO:0045766 | positive regulation of angiogenesis |
| BP | IBA | GO:0048010 | vascular endothelial growth factor receptor signaling pathway |
| BP | TAS | GO:0048010 | vascular endothelial growth factor receptor signaling pathway |
| BP | IEA | GO:0050918 | positive chemotaxis |
| BP | IBA | GO:0050930 | induction of positive chemotaxis |
| BP | IDA | GO:0050930 | induction of positive chemotaxis |
| BP | IEA | GO:0051781 | positive regulation of cell division |
| BP | IBA | GO:0060754 | positive regulation of mast cell chemotaxis |
| BP | IDA | GO:0060754 | positive regulation of mast cell chemotaxis |
| BP | IEA | GO:0071542 | dopaminergic neuron differentiation |
| MF | TAS | GO:0005161 | platelet-derived growth factor receptor binding |
| MF | IPI | GO:0005172 | vascular endothelial growth factor receptor binding |
| MF | IPI | GO:0005515 | protein binding |
| MF | IBA | GO:0008083 | growth factor activity |
| MF | IBA | GO:0042056 | chemoattractant activity |
| MF | IDA | GO:0042056 | chemoattractant activity |
| MF | IEA | GO:0042803 | protein homodimerization activity |
| MF | IBA | GO:0043185 | vascular endothelial growth factor receptor 3 binding |
Gene expression in normal tissue: VEGFD
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in VEGFD
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| reactome | R-HSA-109582 | Hemostasis |
| reactome | R-HSA-114608 | Platelet degranulation |
| reactome | R-HSA-162582 | Signal Transduction |
| reactome | R-HSA-194138 | Signaling by VEGF |
| reactome | R-HSA-194313 | VEGF ligand-receptor interactions |
| reactome | R-HSA-195399 | VEGF binds to VEGFR leading to receptor dimerization |
| reactome | R-HSA-76002 | Platelet activation, signaling and aggregation |
| reactome | R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ |
| reactome | R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases |
| wikipathways | WP306 | Focal Adhesion |
| wikipathways | WP3932 | Focal Adhesion-PI3K-Akt-mTOR-signaling pathway |
| wikipathways | WP4172 | PI3K-Akt Signaling Pathway |
| kegg | hsa04010 | MAPK signaling pathway - Homo sapiens (human) |
| kegg | hsa04014 | Ras signaling pathway - Homo sapiens (human) |
| kegg | hsa04015 | Rap1 signaling pathway - Homo sapiens (human) |
| kegg | hsa04060 | Cytokine-cytokine receptor interaction - Homo sapiens (human) |
| kegg | hsa04151 | PI3K-Akt signaling pathway - Homo sapiens (human) |
| kegg | hsa04510 | Focal adhesion - Homo sapiens (human) |
| kegg | hsa04926 | Relaxin signaling pathway - Homo sapiens (human) |
| kegg | hsa04933 | AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human) |
| kegg | hsa05200 | Pathways in cancer - Homo sapiens (human) |
| pid | integrin_a9b1_pathway | Alpha9 beta1 integrin signaling events |
| pid | lymphangiogenesis_pathway | VEGFR3 signaling in lymphatic endothelium |
| pid | vegf_vegfr_pathway | VEGF and VEGFR signaling network |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD307 | Manumycin A | 3 |
| iGMDRD116 | CD437 | 1 |
| iGMDRD560 | MK-2206 | 3 |
| iGMDRD345 | Compound 10b [PMID: 11504634] | 2 |
| iGMDRD523 | Cyanoquinoline, 11 | 4 |
| iGMDRD871 | BRD6368 | 2 |
| iGMDRD286 | Nsc 632839 | 1 |
| iGMDRD872 | BRD7137 | 3 |
| iGMDRD329 | Merck60 | 2 |
| iGMDRD662 | JQ-1 | 2 |
| iGMDRD246 | NPC26 | 2 |
| iGMDRD42 | Vorinostat | 3 |
| iGMDRD202 | Curcumin | 2 |
| iGMDRD6 | AM-580 | 2 |
| iGMDRD481 | Dactolisib | 4 |
| iGMDRD267 | Oligomycin A | 4 |
| iGMDRD61 | Kinetin riboside | 2 |
| iGMDRD359 | OSW-1 | 3 |
| iGMDRD375 | GW-405833 | 2 |
| iGMDRD554 | CHEMBL1434137 | 2 |
| iGMDRD599 | Salermide | 5 |
| iGMDRD1008 | SR-II-138A | 3 |
| iGMDRD772 | BRD4770 | 2 |
| iGMDRD546 | BMS-754807 | 3 |
| iGMDRD494 | Neopeltolide | 2 |
| iGMDRD781 | Sirolimus | 2 |
| iGMDRD100 | Zebularine | 2 |
| iGMDRD399 | Selumetinib | 5 |
| iGMDRD888 | Compound 44 | 5 |
| iGMDRD562 | Navitoclax | 2 |
| iGMDRD60 | Quinoclamine | 2 |
| iGMDRD524 | ISX-9 | 5 |
| iGMDRD451 | Serdemetan | 2 |
| iGMDRD474 | Avrainvillamide | 3 |
| iGMDRD318 | PAC-1 | 2 |
| iGMDRD885 | Compound 110 | 5 |
| iGMDRD870 | BRD63610 | 2 |
| iGMDRD52 | Rotenone | 2 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in VEGFD

